World's First Bionic Eye Receives FDA Approval

The new retinal prosthesis, called Argus II, can restore partial sight to people blinded by a degenerative eye disease

Bionic Eye

Bionic Eye

This morning, I was speaking with Brian Mech, the vice-president of the medical device company Second Sight, when his land-line rang. Mech had just been telling me about the fifteen years his company has spent developing the Argus II, a retinal prosthesis that restores partial sight to people with a degenerative eye disease called Retinitis pigmentosa (RP). It had been a long process, Mech said, but he can count on one hand the number of days he hasn't woken up excited about the work ahead. And they were nearing the end--Europe approved the Argus II in 2011, and the FDA was expected to give the green light some time soon.